Generics - Financial, Johnson & Johnson

Filter

Popular Filters

Johnson & Johnson close to settling over Risperdal marketing; SEC probes Teva

06-08-2012

US health care giant Johnson & Johnson (NYSE: JNJ) has reached "an agreement in principle'' with the…

FinancialGenericsInvegaJanssenJohnson & JohnsonLegalMarkets & MarketingNatrecorNorth AmericaPharmaceuticalRisperdalTeva Pharmaceutical Industries

Back to top